A Double-Blind, Placebo-Controlled Randomized Evaluation of the Effect of the Erchonia ML Scanner (MLS) on Body Contouring of the Waist, Hips and Thighs Clinical Study Protocol
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Body Contouring
- Sponsor
- Erchonia Corporation
- Enrollment
- 72
- Locations
- 3
- Primary Endpoint
- Incidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference.
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The purpose of this study is to determine whether green diode low level laser therapy is effective for body contouring of the waist, hips and thighs.
Detailed Description
Weight loss and body contouring are large, constantly-growing fields of cosmetic surgery. According to the American Society of Plastic Surgeons (ASPS) statistics, more than 324,000 liposuction procedures, 233,000 eyelid surgeries and 114,000 facelift procedures were performed in 2004 in the United States alone. However, while the demand for body shaping procedures is constantly on the rise, so is the demand for such procedures to be performed more quickly, simply and most importantly, less invasively. Cosmetic surgery patients are no longer satisfied with procedures that require general anesthesia, pose a multitude of potentially serious risks and complications and that require several weeks of recovery time. Hence the growing popularity of non- to minimally-invasive cosmetic surgery procedures. In 2005, more than 7.5 million minimally-invasive cosmetic procedures were performed, a 35% increase from 2000. Consequently, patients and physicians alike are continually searching for non-invasive alternatives to traditional cosmetic procedures such as liposuction that are efficient, safe and effective.
Investigators
Eligibility Criteria
Inclusion Criteria
- •indicated for liposuction for the removal of localized deposits of adipose tissues that do not respond to diet and exercise; specifically in the areas of the waist, hips and bilateral thighs.
- •willing and able to abstain from partaking in any treatment other than the study procedure (existing or new) to promote body contouring and/or weight loss during the course of study participation.
- •willing and able to maintain regular diet and exercise regimen without during study participation.
- •18 to 65 years.
- •Male or female.
Exclusion Criteria
- •Body Mass Index (BMI) of 30 kg/m² or greater.
- •Diabetes dependent on insulin or oral hypoglycemic medications.
- •known cardiovascular disease.
- •cardiac surgeries, pacemakers.
- •excessive alcohol consumption.
- •prior surgical intervention for body sculpting/weight loss.
- •medical, physical, or other contraindications for body sculpting/weight loss.
- •current use of medication(s) known to affect weight levels and/or to cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent.
- •medical condition known to affect weight levels and/or to cause bloating or swelling.
- •diagnosis of, and/or taking medication for, irritable bowel syndrome.
Outcomes
Primary Outcomes
Incidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference.
Time Frame: 2 weeks